1. Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID‐19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell. Issue 1 (24th January 2023) Authors: Perram, Jacinta; Purtill, Duncan; Bajel, Ashish; Butler, Jason; O'Brien, Tracey; Teh, Benjamin; Gilroy, Nicole; Ho, Phoebe J.; Doocey, Richard; Hills, Thomas; Perera, Travis; Douglas, Genevieve; Ramachandran, Shanti; Chee, Lynette; Trotman, Judith; Weinkove, Robert; Keogh, Steven; Fraser, Chris; ... Journal: Internal medicine journal Issue: Volume 53:Issue 1(2023) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Australia and New Zealand Transplant and Cellular Therapies COVID‐19 vaccination consensus position statement. Issue 8 (22nd August 2021) Authors: Hamad, Nada; Ananda‐Rajah, Michelle; Gilroy, Nicole; MacIntyre, Raina; Gottlieb, David; Ritchie, David; Harrison, Simon; Kennedy, Glen; Watson, Anne M.; Greenwood, Matthew; Doocey, Richard; Perera, Travis; Spencer, Andrew; Wong, Eric; O'Brien, Tracey; Shaw, Peter; Conyers, Rachel; Milliken, Samue... Journal: Internal medicine journal Issue: Volume 51:Issue 8(2021) Page Start: 1321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bone Marrow Transplant Society of Australia and New Zealand COVID‐19 consensus position statement. Issue 6 (14th June 2020) Authors: Hamad, Nada; Gottlieb, David; Ritchie, David; Kennedy, Glen; Watson, Anne M.; Greenwood, Matthew; Doocey, Richard; Perera, Travis; Spencer, Andrew; Wong, Eric; O'Brien, Tracey; Shaw, Peter; Conyers, Rachel; Cole, Theresa; Milliken, Sam; Bardy, Peter; Larsen, Stephen; Lai, Hock; Butler, Andrew; Fr... Journal: Internal medicine journal Issue: Volume 50:Issue 6(2020) Page Start: 774 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma. Issue 7 (2nd July 2016) Authors: Thompson, Philip A.; Perera, Travis; Marin, David; Oran, Betul; Popat, Uday; Qazilbash, Muzaffar; Shah, Nina; Parmar, Simrit; Rezvani, Katayoun; Olson, Amanda; Kebriaei, Partow; Anderlini, Paolo; Rondon, Gabriela; Alousi, Amin; Ciurea, Stefan; Champlin, Richard E.; Bajel, Ashish; Szer, Jeffrey; S... Journal: Leukemia & lymphoma Issue: Volume 57:Issue 7(2016:Jul.) Page Start: 1607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The role of a specialist bridging service. A New Zealand prospective study of 600 patients. (1st August 2019) Authors: Ruell, Jackie; Smith, Alison; Perera, Travis; Carter, John Journal: Journal of thrombosis and haemostasis Issue: Volume 17:Number 10(2019) Page Start: 1756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE). Issue 2 (9th February 2020) Authors: George, Philip; Dasyam, Nathaniel; Giunti, Giulia; Mester, Brigitta; Bauer, Evelyn; Andrews, Bethany; Perera, Travis; Ostapowicz, Tess; Frampton, Chris; Li, Peng; Ritchie, David; Bollard, Catherine M; Hermans, Ian F; Weinkove, Robert Journal: BMJ open Issue: Volume 10:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗